Brussels sprouts ‘contain a nutrient which combats dementia’
- Experts creating strong version of acid produced by vitamin A rich vegetables
- In the body vitamin A is turned into retinoic acid, which plays vital role in CNS
- It is particularly important for the eye and brain as the embryo is developing
Daily Mail Reporter
110
View
comments
A pill for Alzheimer’s is on the way thanks to an unlikely source – Brussels sprouts.
Scientists say the festive food contains a nutrient which combats neurological disorders including dementia.
The experts from the universities of Durham and Aberdeen are creating a supercharged version of the acid produced by vitamin A rich vegetables like sprouts, carrots, spinach and tomatoes.
Brussels sprouts: Scientists say the festive food contains a nutrient which combats neurological disorders including dementia
Human trials could begin in the next two years.
In the body vitamin A is turned into retinoic acid, which then interacts with specific receptors and plays a vital role in the human central nervous system.
It is particularly important for the eye and brain as the embryo is developing.
In the adult brain retinoic acid is believed to play a different, more ‘focussed’ role and there are suggestions it could affect neural disorders, both degenerative and psychiatric.
-
Christmas miracle! 89-year-old man with dementia is found…
Why we lose our memories when we age – and what you can do…
Professor Peter McCaffery, of the University of Aberdeen, explained: ‘When we eat Brussels sprouts it increases the amount of this acid in the brain.
‘We are not saying doubling your portion of sprouts over Christmas will stop you getting Alzheimer’s. That would be the wrong message.
‘But they are good for the body, so that means they are good for the brain. The compound we are developing works on exactly the same receptors as the acid from Brussels sprouts.
A pill for Alzheimer’s is on the way thanks to an unlikely source – Brussels sprouts (file image)
‘The evidence is it will boost the number of neurons and the connections between them.’
His team and experts at the University of Durham and chemical development company High Force Research are now set to begin a £250,000 two year project funded by the Biotechnology and Biological Sciences Research Council (BBSRC).
They have designed synthetic versions of retinoic acid that interact with the body’s natural receptors in the brain in an even more powerful way than the regular type.
They hope to progress to therapeutics – mainly for Alzheimer’s but potentially Parkinson’s disease and other neurodegenerative conditions.
Another unique aspect of the study is the method used to screen the new synthetic compounds, making the process more efficient.
With the cost of drug discovery rising and the time to develop new drugs increasing, this new process is another important factor that contributed to the project being identified for further funding.
There are 850,000 people in the UK living with dementia, a figure forecast to rise to more than a million by 2025, and over two million by 2051.
Last month it became Britain’s biggest killer, overtaking heart disease as the leading cause of death in England and Wales.
In 2015 it claimed the lives of more than 61,000, 11.6 percent of all recorded deaths.
Share or comment on this article
-
e-mail
-
SWAT teams dispatched, families flee from ‘gunfire’ and…
-
Star Wars actress Carrie Fisher dies aged 60 four days after…
-
It’s my quinceañera and I’ll cry if I want to! Mexican girl…
-
‘NO WAY’: Trump mocks Obama for saying he could have beaten…
-
‘Step Up’ actress, 46, who vanished on her way to Christmas…
-
‘He became a recluse because he couldn’t bear people to see…
-
Bikini-clad Ivanka Trump and shirtless husband Jared enjoy a…
-
Why does the duchess always have a plaster on her hand?…
-
The Texas border lake where Mexican cartels ‘are killing…
-
George Michael’s £100m fortune ‘will go to his Godchildren’:…
-
Nigerian female suicide bomber is lynched and killed by a…
-
‘I’ll never stop missing you’: George Michael’s lover is…
Find out now